Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.38%3.65B | -5.12%1.17B | 2.71%911M | 36.46%988M | 54.07%587M | 25.22%3.22B | 63.13%1.23B | 24.06%887M | -2.69%724M | 5.83%381M |
Operating revenue | 2.98%3.32B | -13.25%1.07B | -4.40%848M | 17.82%853M | 44.36%550M | 25.22%3.22B | 63.13%1.23B | 24.06%887M | -2.69%724M | 5.83%381M |
Cost of revenue | 11.07%2.49B | -5.00%855M | -3.25%595M | 41.23%733M | 48.06%305M | 28.00%2.24B | 70.78%900M | 24.49%615M | -2.81%519M | 5.64%206M |
Gross profit | 18.64%1.17B | -5.45%312M | 16.18%316M | 24.39%255M | 61.14%282M | 19.32%982M | 45.37%330M | 23.08%272M | -2.38%205M | 6.06%175M |
Operating expense | 12.85%773M | -0.48%207M | 23.03%203M | 20.92%185M | 11.95%178M | 5.38%685M | 11.83%208M | 5.10%165M | -4.97%153M | 8.90%159M |
Selling and administrative expenses | 29.11%408M | 21.51%113M | 43.04%113M | 31.88%91M | 21.33%91M | 9.72%316M | -3.13%93M | 16.18%79M | 1.47%69M | 33.93%75M |
Depreciation amortization depletion | -4.61%352M | -22.61%89M | 2.33%88M | 5.95%89M | 2.38%86M | 1.93%369M | 27.78%115M | -3.37%86M | -9.68%84M | -6.67%84M |
-Depreciation and amortization | -4.61%352M | -22.61%89M | 2.33%88M | 5.95%89M | 2.38%86M | 1.93%369M | 27.78%115M | -3.37%86M | -9.68%84M | -6.67%84M |
Other operating expenses | --13M | --5M | --2M | --5M | --1M | ---- | ---- | ---- | ---- | ---- |
Operating profit | 31.99%392M | -13.93%105M | 5.61%113M | 34.62%70M | 550.00%104M | 71.68%297M | 197.56%122M | 67.19%107M | 6.12%52M | -15.79%16M |
Net non-operating interest income expense | 2.80%-208M | 13.21%-46M | 3.57%-54M | 1.85%-53M | -7.84%-55M | -43.62%-214M | -8.16%-53M | -36.59%-56M | -80.00%-54M | -75.86%-51M |
Non-operating interest expense | -2.80%208M | -13.21%46M | -3.57%54M | -1.85%53M | 7.84%55M | 43.62%214M | 8.16%53M | 36.59%56M | 80.00%54M | 75.86%51M |
Other net income (expense) | -230.47%-167M | -1,547.06%-280M | -42.86%56M | -95.28%6M | 163.75%51M | -43.61%128M | -123.61%-17M | 24.05%98M | 28.28%127M | -247.83%-80M |
Gain on sale of security | -385.71%-120M | -402.44%-206M | -40.91%39M | -101.56%-1M | 202.13%48M | -63.48%42M | -373.33%-41M | 175.00%66M | -22.89%64M | -571.43%-47M |
Earnings from equity interest | -150.00%-10M | -33.33%-4M | -150.00%-1M | -100.00%-2M | -50.00%-3M | ---4M | ---3M | 100.00%2M | 0.00%-1M | ---2M |
Special income (charges) | ---105M | ---82M | ---3M | ---11M | ---9M | --0 | --0 | ---- | --0 | --0 |
-Write off | --105M | --82M | --3M | --11M | --9M | --0 | --0 | ---- | --0 | --0 |
Other non- operating income (expenses) | -24.44%68M | -55.56%12M | -30.00%21M | -68.75%20M | 148.39%15M | -19.64%90M | -52.63%27M | -44.44%30M | 276.47%64M | -93.75%-31M |
Income before tax | -91.94%17M | -525.00%-221M | -22.82%115M | -81.60%23M | 186.96%100M | -15.94%211M | -18.75%52M | 46.08%149M | 5.93%125M | -248.48%-115M |
Income tax | 74.07%47M | 437.50%27M | -106.45%-2M | -110.00%-1M | 483.33%23M | 108.68%27M | 97.43%-8M | 487.50%31M | 66.67%10M | -400.00%-6M |
Net income | -116.30%-30M | -513.33%-248M | -0.85%117M | -79.13%24M | 170.64%77M | -67.26%184M | -84.00%60M | 7.27%118M | 2.68%115M | -211.43%-109M |
Net income continuous Operations | -116.30%-30M | -513.33%-248M | -0.85%117M | -79.13%24M | 170.64%77M | -67.26%184M | -84.00%60M | 7.27%118M | 2.68%115M | -211.43%-109M |
Net income discontinuous operations | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
Minority interest income | 0 | 0 | 0 | 0 | 0 | -125.00%-1M | 0 | 0 | -200.00%-1M | 0 |
Net income attributable to the parent company | -116.22%-30M | -513.33%-248M | -0.85%117M | -79.31%24M | 170.64%77M | -66.85%185M | -83.96%60M | 9.26%118M | 4.50%116M | -211.43%-109M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -116.22%-30M | -513.33%-248M | -0.85%117M | -79.31%24M | 170.64%77M | -66.85%185M | -83.96%60M | 9.26%118M | 4.50%116M | -211.43%-109M |
Basic earnings per share | -116.46%-0.13 | -503.85%-1.05 | -4.00%0.48 | -80.00%0.1 | 170.21%0.33 | -66.95%0.79 | -83.75%0.26 | 8.70%0.5 | 4.17%0.5 | -213.33%-0.47 |
Diluted earnings per share | -120.97%-0.13 | -520.00%-1.05 | 23.08%0.48 | -75.61%0.1 | 155.17%0.32 | -71.16%0.62 | -83.87%0.25 | 25.81%0.39 | 17.14%0.41 | -286.67%-0.58 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |